publication . Article . 2009

La ciclooxigenasa-2 (COX-2) y el factor de crecimiento epidérmico (EFG) en lesiones epiteliales orales premalignas

L. M. Antón Aparicio; A. Gallego Guadalupe; J. Ferreras Granado; S. Díaz Prado; J.L. López-Cedrún;
Open Access Spanish
  • Published: 01 Jun 2009
  • Publisher: Sociedad Española de Cirugía Oral y Maxilofacial y de Cabeza y Cuello
  • Country: Spain
Abstract
[Resumen] Las lesiones premalignas orales incluyen eritroplasias (manchas rojas) y leucoplasias (manchas blancas), las cuales se desarrollan a lo largo de superficies epiteliales. Estas lesiones son considerados marcadores en la “car- cinogénesis de campo” ya que pacientes con lesiones premalignas orales pue- den desarrollar carcinoma de células escamosas (CCS) en el sitio de las lesio- nes, así como en otros lugares de tracto aerodigestivo superior. Se está hacien- do un gran esfuerzo para identificar nuevos biomarcadores SEBs (surrogate endpoint biomarkers) para el carcinoma de células escamosas de cabeza y cue- llo. Los SEBs candidatos para el carcinoma de cé...
Subjects
free text keywords: Factor de crecimiento epidérmico, Ciclooxigenasa-2, Carcinoma de células escamosas de cabeza y cuello, Lesión premaligna oral, Biomarcador, Carcinogénesis de campo, Epidermal growth factor, Cyclooxygenase-2, Head and neck squamous cell carcinoma, Oral premalignant lesion, Biomarker, Field cancerization, Surgery, Oral Surgery, Otorhinolaryngology, Gynecology, medicine.medical_specialty, medicine, business.industry, business
Related Organizations
23 references, page 1 of 2

1. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004;5:311-6.

2. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002;21:4231-6.

3. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54. [OpenAIRE]

4. Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, y cols. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res 2004;10:1733-42.

5. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, Dubois RN. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for cheomoprevention. J Clin Oncol 2005;23:254-66.

6. Lippman SM, Sudbo J, Hong WK. Oral cancer prevention and the evolution of molecular targeted drug development. J Clin Oncol 2005;23:346-56.

Rev Esp Cir Oral Maxilofac 2009;31,3 (mayo-junio):170-181 © 2009 ergon 181

7. Wiese FW, Thompson PA & Kadlubar FF. Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis 2001;21:5-10.

8. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105:1589-94.

9. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, et al. Cyclooxygenase2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-4.

10. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, y cols. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 2001;3:53-61.

11. Schlessinger J. Cell signaling by receptor tyrosine kinase. Cell 2000;103:211- 25. [OpenAIRE]

12. Yarden Y, Sliwkowski M. Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2001;2:127-37. [OpenAIRE]

13. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J 2000;19:3159-67.

14. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase-Akt pathway in human cancer. Nat Rev Cancer 2002;2:489-501.

23 references, page 1 of 2
Any information missing or wrong?Report an Issue